Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

4.34
-0.2200-4.82%
Pre-market: 4.410.0700+1.61%07:37 EDT
Volume:2.98M
Turnover:13.13M
Market Cap:374.16M
PE:-1.15
High:4.56
Open:4.50
Low:4.28
Close:4.56
52wk High:19.11
52wk Low:3.95
Shares:86.21M
Float Shares:60.67M
Volume Ratio:1.01
T/O Rate:4.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:2.25
PE(LYR):-1.37

Loading ...

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

EyePoint Price Target Cut to $4.00/Share from $20.00 by TD Cowen

Dow Jones
·
Sep 02

TD Cowen Downgrades EyePoint Pharmaceuticals to Hold From Buy, Adjusts PT to $4 From $20

MT Newswires Live
·
Sep 02

EyePoint to Join Citi, Cantor and Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 02

EyePoint downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Sep 02

U.S. Research Roundup-Adobe, Dell Technologies, Zscaler

Reuters
·
Sep 02

EyePoint Inc : TD Cowen Cuts to Hold from Buy; Cuts Target Price to $4 from $20

THOMSON REUTERS
·
Sep 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
Sep 02

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Sweden's SynAct Pharma Q2 Net Loss Narrows on Lower Expenses

Reuters
·
Aug 20

Analyst Maintains Buy on Duravyu, Cutting Price Target to $20 Amid LUCIA Trial Binary Risk

TIPRANKS
·
Aug 19

Iridex Q2 Revenue Falls as Retina Sales Decline

Reuters
·
Aug 19

EyePoint Director Karen Zaderej Reports Purchase of 10,600 Shares Worth $52,258

Reuters
·
Aug 19

EyePoint is Maintained at Buy by Citigroup

Dow Jones
·
Aug 19

EyePoint Faces Regulatory Uncertainty After Lugano Trial Miss, RBC Capital Markets Says

MT Newswires Live
·
Aug 18

U.S. Stocks on the MOVE-Dynatrace, Duolingo, Baidu Inc

Reuters
·
Aug 18

EyePoint Inc : H.c. Wainwright Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 18

EyePoint (EYPT) Following LUGANO Data Is The Undervalued Narrative Still Intact

Simply Wall St.
·
Aug 18

EyePoint Falls After Experimental Drug Misses Goal, Brokerages Cut Ratings

Reuters
·
Aug 18

EyePoint Inc : Jefferies Cuts Target Price to $8 from $30

THOMSON REUTERS
·
Aug 18